(Q73265742)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9118024%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9118024%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

4

Y Shoenfeld

1 reference

2 November 2019

1

P Fishman

1 reference

2 November 2019

O Merimski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9118024%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Baharav

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9118024%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9118024%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9118024%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9118024%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9118024%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1461-1464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9118024%20AND%20SRC:MED&resulttype=core&format=json

Tyrosinase as an autoantigen in patients with vitiligo

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Anti-tyrosinase antibodies in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Vitiligo autoantibodies are effective against melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Cloning and expression of cDNA encoding mouse tyrosinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Melanin production in cultured albino melanocytes transfected with mouse tyrosinase cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Generalized melanosis secondary to malignant melanoma. Report of a case with serum and tissue tyrosinase studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Malignant melanoma of the head and neck. Clinical and immunological considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

The role of tyrosinase in autoimmune vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Prognostic significance of hypopigmentation in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Vitiligo in patients with metastatic melanoma: a good prognostic sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Antigens and antibodies in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Human high molecular weight-melanoma associated antigen as a target for active specific immunotherapy--a phase I clinical trial with murine antiidiotypic monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970415%2979%3A8%3C1461%3A%3AAID-CNCR3%3E3.0.CO%3B2-E

10.1002/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO;2-E

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9118024%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference